No substantial difference in HIV risk among women using most common birth control
No substantial difference in HIV risk among women using most common birth control
Now we know! Using DMPA-IM, copper IUD and ING implant doesn’t lead to increased women’s risk for HIV infections (when it is combined with high quality HIV/STI services). This shows the Evidence for Contraceptive Options and HIV Outcomes (ECHO) study, released on June 13, 2019.
The results of the ECHO trial are of major significance to women and girls -especially in East and Southern Africa- providers, policy makers, funders and advocates.
From 2015 to 2018 the ECHO trial was conducted in four countries, Swaziland, Kenya, South Africa and Zambia. The study was done to gather information about how different methods affect risk, whether increasing or possibly decreasing it. Women need to know whether certain contraceptives increase their chances of getting HIV.
Conclusions
- No substantial difference in HIV risk among the methods evaluated, and all methods were safe and highly effective.
- Each method had high levels of safety and effectiveness in preventing pregnancy
- Need for increased access to contraceptive methods, as well as expanded contraceptive choices, complemented by high-quality HIV and STI prevention services. In particular young women are at high risk and services must meet where they are.
More info about the ECHO trial results can be found at the AVAC website.